Method of treating abnormal cell growth

Details for Australian Patent Application No. 2006323027 (hide)

Owner Pfizer Products Inc

Inventors Zou, Yahong; Christensen, James Gail

Agent Allens Patent & Trade Mark Attorneys

Pub. Number AU-B-2006323027

PCT Pub. Number WO2007/066187

Priority 60/864,637 07.11.06 US; 60/742,766 05.12.05 US

Filing date 23 November 2006

Wipo publication date 14 June 2007

Acceptance publication date 2 August 2012

International Classifications

A61K 31/4545

A61P 35/00 Antineoplastic agents

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/066187 Priority application(s): WO2007/066187

26 June 2008 Alteration of Name

  The name of the applicant has been altered to Pfizer Products Inc 2007

2 August 2012 Application Accepted

  Published as AU-B-2006323027

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006323028-Marked bovine viral diarrhea virus vaccines

2006323025-Polymorphs of a c-Met/HGFR inhibitor